Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -37.505% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCOc1cc(S(=O)(=O)Nc2ccc(CC)cc2)ccc1Cl
(b) CC1CCN(c2ccc3nnc(CCC(=O)Nc4cc(F)ccc4F)n3n2)CC1
Answer: b. CC1CCN(c2ccc3nnc(CCC(=O)Nc4cc(F)ccc4F)n3n2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(c2ccc3nnc(CCC(=O)Nc4cc(F)ccc4F)n3n2)CC1
CC1CCN(c2ccc3nnc(CCC(=O)Nc4cc(F)ccc4F)n3n2)CC1
N-(2,5-difluorophenyl)-3-[6-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanamide